Trough (C0) and 2-hour postdose (C2) cyclosporine monitoring in patients with moderate-to-severe psoriasis

被引：0
|
作者：
Herrero-Moyano, M. [1 ]
Pedraz, J. [1 ]
Munoz-Aceituno, E. [1 ]
Chicharro, P. [1 ]
Reolid, A. [1 ]
Lara, S. [2 ]
Dauden, E. [1 ]
机构：
[1] Hosp Univ La Princesa, Dept Dermatol, Madrid, Spain
[2] Hosp Univ La Princesa, Clin Anal Dept, Madrid, Spain
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2019年 / 33卷 / 05期
关键词：
TRANSPLANT RECIPIENTS; MICROEMULSION; EFFICACY; TIME;
D O I：
10.1111/jdv.15481
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E215 / E217
页数：4
相关论文
共 50 条
  • [31] χc0 and χc2 decays into ηη, ηη′, and η′η′ final states
    Adams, G. S.
    Anderson, M.
    Cummings, J. P.
    Danko, I.
    Napolitano, J.
    He, Q.
    Insler, J.
    Muramatsu, H.
    Park, C. S.
    Thorndike, E. H.
    Yang, F.
    Coan, T. E.
    Gao, Y. S.
    Artuso, M.
    Blusk, S.
    Butt, J.
    Li, J.
    Menaa, N.
    Mountain, R.
    Nisar, S.
    Randrianarivony, K.
    Sia, R.
    Skwarnicki, T.
    Stone, S.
    Wang, J. C.
    Zhang, K.
    Csorna, S. E.
    Bonvicini, G.
    Cinabro, D.
    Dubrovin, M.
    Lincoln, A.
    Asner, D. M.
    Edwards, K. W.
    Briere, R. A.
    Chen, J.
    Ferguson, T.
    Tatishvili, G.
    Vogel, H.
    Watkins, M. E.
    Rosner, J. L.
    Adam, N. E.
    Alexander, J. P.
    Berkelman, K.
    Cassel, D. G.
    Duboscq, J. E.
    Ecklund, K. M.
    Ehrlich, R.
    Fields, L.
    Galik, R. S.
    Gibbons, L.
    PHYSICAL REVIEW D, 2007, 75 (07):
  • [32] Comparison of Neoral® dose monitoring with C0 and C2 in stable renal tranplant patients.
    Marcen, R
    Tato, AM
    Pascual, J
    Merino, JL
    Villafruela, JJ
    Teruel, JL
    Rivera, ME
    Burgos, FJ
    Ortuno, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 370A - 371A
  • [33] Cyclosporine dose reduction in stable renal transplant patients with high C2 level: simplified method of single C2 measurement and individualization of C0 target
    Higgins, RM
    Kanji, H
    Hernon, M
    Harrison, P
    Lam, FT
    Kashi, SH
    TRANSPLANT INTERNATIONAL, 2005, 18 (07) : 806 - 810
  • [34] Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients
    Paydas, S
    Balal, M
    Sertdemir, Y
    Seyrek, N
    Karayaylali, I
    RENAL FAILURE, 2005, 27 (04) : 409 - 413
  • [35] Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients:: A prospective randomized single-center pilot study
    Kyllönen, LE
    Salmela, KT
    TRANSPLANTATION, 2006, 81 (07) : 1010 - 1015
  • [36] Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction
    Cantarovich, M
    Quantz, M
    Elstein, E
    Ergina, P
    Magnan, C
    de Varennes, B
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (02) : 446 - 448
  • [37] Cyclosporine maintenance dose and a challenge of achieving target levels:: Application of monitoring C0 versus C2 in infant with autoimmune enteritis
    Tesfaye, Hundie
    Bronsky, Jiri
    Nevoral, Jiri
    Prusa, Richard
    Jedlickova, Blanka
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 540 - 540
  • [38] Impact of late conversion from C0 to C2 monitoring of microemulsified cyclosporine in pediatric living donor liver transplant recipients
    Takatsuki, M
    Chen, CL
    Chen, YS
    Wang, CC
    Lin, CC
    Yang, CH
    Yong, CC
    Liu, YW
    CLINICAL TRANSPLANTATION, 2004, 18 (06) : 694 - 699
  • [39] Switching monitoring of emulsified cyclosporine from trough level to 2-hour level in stable liver transplant patients
    Langers, P
    Cremers, SCLM
    den Hartigh, J
    Veenendaal, RA
    ten Hove, WR
    Ringers, J
    Lamers, CBHW
    van Hoek, B
    LIVER TRANSPLANTATION, 2004, 10 (02) : 183 - 189
  • [40] Neoral drug monitoring in stable kidney allotransplant recipients:: C0 versus C2
    Lukaschek, J
    Hofmann, J
    Aerne, D
    Ambühl, P
    Kistler, T
    Knoflach, A
    Pei, P
    Binswanger, U
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3104 - 3105
12345